SIG
TEVA icon

Spinnaker Investment Group’s Teva Pharmaceuticals TEVA Stock Holding History

Spinnaker Investment Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,700
Closed -$322K – 194
2026
Q1 		$322K Hold
10,700
– – 0.07% 103
2025
Q4 		$334K Sell
10,700
-15,000
-58% -$370K 0.06% 122
2025
Q3 		$519K Buy
+25,700
New +$451K 0.1% 78

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Spinnaker Investment Group's TEVA Position: Q2 2026 in Review

Spinnaker Investment Group sold out of Teva Pharmaceuticals (TEVA) in Q2 2026, closing a stake of 10,700 shares — an estimated $322K sold.

Spinnaker Investment Group first reported a position in TEVA in Q3 2025 and held it in 3 quarters. The position peaked at $519K in Q3 2025. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Spinnaker Investment Group reported no remaining Teva Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Spinnaker Investment Group sold 10,700 Teva Pharmaceuticals shares in Q2 2026, an estimated $322K.
  • Spinnaker Investment Group first reported a position in Teva Pharmaceuticals in Q3 2025 and held it in 3 quarters.
  • Spinnaker Investment Group's Teva Pharmaceuticals position peaked at $519K in Q3 2025.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Spinnaker Investment Group's 13F filing for Q2 2026, filed 10 Jul 2026.